Colman to address Sydney conference

By Iain Scott
Monday, 03 March, 2003

Cloning pioneer Alan Colman, the director of research programs with Singapore company ES Cell International, will visit Sydney in May to address a conference on prospects for stem cell therapy.

The conference, Discovery Science and Biotechnology, will be held at Sydney's Cockle Bay Wharf on May 15 and 16.

As well as Colman, the conference will feature Dr Andrew Fraser of Cambridge's Sanger Institute, whose work involves using genome-wide RNAi approaches to determine gene function.

The conference will present some of the latest research in seven broad streams -- genetic origins of disease, functional genomics, innovation and commercialisation, proteomics, genomics, SNPs in gene discovery and personalised medicine, and stem cell biotechnology.

Each stream will feature papers by eminent scientists from Australia and abroad, including Simon Easteal on genome diversity and disease, Deon Venter on arrays and expression profiling, Ian Smith on high-throughput automated proteomics, Robin Anders on protein structure, Deborah Rathjen on commercialising innovation, Rohan Teasdale on reverse transcription.

For more information, visit magicdatabases.com/dsb.html, or call (02) 9524 1744. Discount registration is available to delegates who book before March 14.

Related News

Repurposed drugs show promise in heart muscle regeneration

The FDA-approved medications, when given in combination, target two proteins that regulate the...

A pre-emptive approach to treating leukaemia relapse

The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...

Long COVID abnormalities appear to resolve over time

Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd